HDL Deficiency and Atherosclerosis:
The tandem pace of medical knowledge and prevention of ischaemic heart disease over the past 50 years is testimony to the effectiveness of a combination of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware ness. The death rat...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
1995
|
| Schriftenreihe: | Developments in Cardiovascular Medicine
174 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The tandem pace of medical knowledge and prevention of ischaemic heart disease over the past 50 years is testimony to the effectiveness of a combination of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at a rate over 50% lower. Numerous factors have contributed to this success. By 1950 lipoproteins had just been discovered, but a decade later a great surge in research had focussed upon plasma cholesterol and lipoprotein concentrations as major predictors of risk. Today, a continuing expansion and sophistica tion of that research has removed all doubt about the significance of particular patterns. The pathway to ideal prophylaxis, however, particu larly for risks associated with inherited lipoprotein disorders, still awaits the untangling of great amounts of new information that continue to rise from application of molecular technology. This volume deals with many of the contemporary puzzles. One theme revolves about the high density lipoproteins. For twenty years the HDL have been considered a defence against the caprices of the LDL, now believed to be particularly villainous after oxidation |
| Beschreibung: | 1 Online-Ressource (96 p) |
| ISBN: | 9789401165853 |
| DOI: | 10.1007/978-94-011-6585-3 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046144688 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1995 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401165853 |9 978-94-011-6585-3 | ||
| 024 | 7 | |a 10.1007/978-94-011-6585-3 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-011-6585-3 | ||
| 035 | |a (OCoLC)1118998830 | ||
| 035 | |a (DE-599)BVBBV046144688 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 084 | |a YC 1103 |0 (DE-625)153185:12909 |2 rvk | ||
| 245 | 1 | 0 | |a HDL Deficiency and Atherosclerosis |c edited by G. Assmann |
| 246 | 1 | 3 | |a Proceedings of a symposium on 'HDL Deficiency and Atherosclerosis', held in Münster, Germany, September 7, 1994 |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 1995 | |
| 300 | |a 1 Online-Ressource (96 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Developments in Cardiovascular Medicine |v 174 | |
| 520 | |a The tandem pace of medical knowledge and prevention of ischaemic heart disease over the past 50 years is testimony to the effectiveness of a combination of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at a rate over 50% lower. Numerous factors have contributed to this success. By 1950 lipoproteins had just been discovered, but a decade later a great surge in research had focussed upon plasma cholesterol and lipoprotein concentrations as major predictors of risk. Today, a continuing expansion and sophistica tion of that research has removed all doubt about the significance of particular patterns. The pathway to ideal prophylaxis, however, particu larly for risks associated with inherited lipoprotein disorders, still awaits the untangling of great amounts of new information that continue to rise from application of molecular technology. This volume deals with many of the contemporary puzzles. One theme revolves about the high density lipoproteins. For twenty years the HDL have been considered a defence against the caprices of the LDL, now believed to be particularly villainous after oxidation | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Cardiology | |
| 650 | 0 | 7 | |a Arteriosklerose |0 (DE-588)4068866-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a High-density-Lipoproteine |0 (DE-588)4159842-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Arteriosklerose |0 (DE-588)4068866-5 |D s |
| 689 | 0 | 1 | |a High-density-Lipoproteine |0 (DE-588)4159842-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Assmann, G. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401165877 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792388883 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401165860 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-6585-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524873 | ||
| 966 | e | |u https://doi.org/10.1007/978-94-011-6585-3 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180480395837440 |
|---|---|
| any_adam_object | |
| author2 | Assmann, G. |
| author2_role | edt |
| author2_variant | g a ga |
| author_facet | Assmann, G. |
| building | Verbundindex |
| bvnumber | BV046144688 |
| classification_rvk | YC 1103 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-011-6585-3 (OCoLC)1118998830 (DE-599)BVBBV046144688 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-011-6585-3 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03339nmm a2200517zcb4500</leader><controlfield tag="001">BV046144688</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1995 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401165853</subfield><subfield code="9">978-94-011-6585-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-6585-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-6585-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118998830</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144688</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 1103</subfield><subfield code="0">(DE-625)153185:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HDL Deficiency and Atherosclerosis</subfield><subfield code="c">edited by G. Assmann</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Proceedings of a symposium on 'HDL Deficiency and Atherosclerosis', held in Münster, Germany, September 7, 1994</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (96 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Developments in Cardiovascular Medicine</subfield><subfield code="v">174</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The tandem pace of medical knowledge and prevention of ischaemic heart disease over the past 50 years is testimony to the effectiveness of a combination of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at a rate over 50% lower. Numerous factors have contributed to this success. By 1950 lipoproteins had just been discovered, but a decade later a great surge in research had focussed upon plasma cholesterol and lipoprotein concentrations as major predictors of risk. Today, a continuing expansion and sophistica tion of that research has removed all doubt about the significance of particular patterns. The pathway to ideal prophylaxis, however, particu larly for risks associated with inherited lipoprotein disorders, still awaits the untangling of great amounts of new information that continue to rise from application of molecular technology. This volume deals with many of the contemporary puzzles. One theme revolves about the high density lipoproteins. For twenty years the HDL have been considered a defence against the caprices of the LDL, now believed to be particularly villainous after oxidation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arteriosklerose</subfield><subfield code="0">(DE-588)4068866-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">High-density-Lipoproteine</subfield><subfield code="0">(DE-588)4159842-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arteriosklerose</subfield><subfield code="0">(DE-588)4068866-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">High-density-Lipoproteine</subfield><subfield code="0">(DE-588)4159842-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Assmann, G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401165877</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792388883</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401165860</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-6585-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524873</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-6585-3</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV046144688 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:26Z |
| institution | BVB |
| isbn | 9789401165853 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524873 |
| oclc_num | 1118998830 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (96 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Springer Netherlands |
| record_format | marc |
| series2 | Developments in Cardiovascular Medicine |
| spelling | HDL Deficiency and Atherosclerosis edited by G. Assmann Proceedings of a symposium on 'HDL Deficiency and Atherosclerosis', held in Münster, Germany, September 7, 1994 Dordrecht Springer Netherlands 1995 1 Online-Ressource (96 p) txt rdacontent c rdamedia cr rdacarrier Developments in Cardiovascular Medicine 174 The tandem pace of medical knowledge and prevention of ischaemic heart disease over the past 50 years is testimony to the effectiveness of a combination of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at a rate over 50% lower. Numerous factors have contributed to this success. By 1950 lipoproteins had just been discovered, but a decade later a great surge in research had focussed upon plasma cholesterol and lipoprotein concentrations as major predictors of risk. Today, a continuing expansion and sophistica tion of that research has removed all doubt about the significance of particular patterns. The pathway to ideal prophylaxis, however, particu larly for risks associated with inherited lipoprotein disorders, still awaits the untangling of great amounts of new information that continue to rise from application of molecular technology. This volume deals with many of the contemporary puzzles. One theme revolves about the high density lipoproteins. For twenty years the HDL have been considered a defence against the caprices of the LDL, now believed to be particularly villainous after oxidation Cardiology Arteriosklerose (DE-588)4068866-5 gnd rswk-swf High-density-Lipoproteine (DE-588)4159842-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Arteriosklerose (DE-588)4068866-5 s High-density-Lipoproteine (DE-588)4159842-8 s DE-604 Assmann, G. edt Erscheint auch als Druck-Ausgabe 9789401165877 Erscheint auch als Druck-Ausgabe 9780792388883 Erscheint auch als Druck-Ausgabe 9789401165860 https://doi.org/10.1007/978-94-011-6585-3 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | HDL Deficiency and Atherosclerosis Cardiology Arteriosklerose (DE-588)4068866-5 gnd High-density-Lipoproteine (DE-588)4159842-8 gnd |
| subject_GND | (DE-588)4068866-5 (DE-588)4159842-8 (DE-588)4143413-4 |
| title | HDL Deficiency and Atherosclerosis |
| title_alt | Proceedings of a symposium on 'HDL Deficiency and Atherosclerosis', held in Münster, Germany, September 7, 1994 |
| title_auth | HDL Deficiency and Atherosclerosis |
| title_exact_search | HDL Deficiency and Atherosclerosis |
| title_full | HDL Deficiency and Atherosclerosis edited by G. Assmann |
| title_fullStr | HDL Deficiency and Atherosclerosis edited by G. Assmann |
| title_full_unstemmed | HDL Deficiency and Atherosclerosis edited by G. Assmann |
| title_short | HDL Deficiency and Atherosclerosis |
| title_sort | hdl deficiency and atherosclerosis |
| topic | Cardiology Arteriosklerose (DE-588)4068866-5 gnd High-density-Lipoproteine (DE-588)4159842-8 gnd |
| topic_facet | Cardiology Arteriosklerose High-density-Lipoproteine Aufsatzsammlung |
| url | https://doi.org/10.1007/978-94-011-6585-3 |
| work_keys_str_mv | AT assmanng hdldeficiencyandatherosclerosis AT assmanng proceedingsofasymposiumonhdldeficiencyandatherosclerosisheldinmunstergermanyseptember71994 |